Synthetic DNA Market Size Worth USD 7.72 Billion by 2034 | CAGR: 18.02%
The market size is expected to reach USD 7.72 billion by 2034, according to a new study by Polaris Market Research. The report “Synthetic DNA Market Size, Share, Trends, & Industry Analysis Report By Product Format, By Synthesis Technology, By Application, By End Use Industry, and By Region; Market Forecast, 2026–2034” offers detailed insight into current market dynamics and analysis of future growth prospects.
The Synthetic DNA Market was valued at USD 1.44 billion in 2025 and is projected to grow at a CAGR of 18.02% from 2026 to 2034. Growth is anchored in the rising dependence of life sciences organizations on externally sourced, custom-designed genetic material, as laboratories look for dependable supply and shorter project lead times.
Advances in production technology are widening what the market can offer. Established chemical methods continue to underpin routine oligonucleotide manufacturing, while enzymatic approaches are opening a path to longer and more intricate sequences. As these methods mature, suppliers are broadening their catalogs from short oligonucleotides to fragments, verified genes, libraries, and large constructs, giving buyers more ways to match product format to project need.
Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Synthetic DNA Market Report
The supplier landscape is shifting alongside these capabilities. Leading providers are widening their catalogs and tightening delivery windows, newer technology entrants are pushing the limits of sequence length, and diagnostic customers are placing greater weight on batch consistency and quality documentation. Biosecurity screening and sequence verification remain integral to how orders are accepted and fulfilled, so suppliers must balance speed with compliance.
Synthetic DNA Market Report Highlights
- The DNA oligonucleotides and pools segment accounted for 54.42% of the market in 2025, while enzymatic synthesis is projected to register the fastest growth among synthesis technologies, at a CAGR of 22.31% through 2034.
- North America held 39.68% of global revenue in 2025, whereas Asia Pacific is expected to expand at a CAGR of 20.12% through 2034, the fastest among all regions.
- Key players in the market include Twist Bioscience Corporation, Integrated DNA Technologies, Inc., Thermo Fisher Scientific Inc., GenScript Biotech Corporation, Eurofins Scientific SE, LGC Biosearch Technologies Limited, BIONEER CORPORATION, Quintara Biosciences, Inc., Ansa Biotechnologies, Inc., DNA Script SAS, Camena Bioscience Ltd., Agilent Technologies, Inc., Azenta, Inc., ATUM, and Synbio Technologies, Inc.
Synthetic DNA Market report on the product format, synthesis technology, application, end use industry, and region:
By Product Format Outlook (Revenue, USD Billion, 2021–2034)
- DNA Oligonucleotides and Pools
- Gene Fragments
- Verified Genes
- Custom Constructs and Libraries
By Synthesis Technology Outlook (Revenue, USD Billion, 2021–2034)
- Chemical Synthesis
- Enzymatic Synthesis
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Research and Engineering
- Diagnostics
- Therapeutic Development
By End Use Industry Outlook (Revenue, USD Billion, 2021–2034)
- Pharmaceutical and Biotechnology Companies
- Academic and Public Research Institutes
- Diagnostic Organizations
- Industrial and Agricultural Biotechnology Organizations
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
